Skip to content

Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation

Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06767579
Enrollment
350
Registered
2025-01-10
Start date
2024-10-24
Completion date
2028-10-17
Last updated
2025-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma, Liver Cirrhosis

Brief summary

This study is a prospective observational study that analyzes the incidence of postoperative delirium in patients undergoing liver transplantation, based on the use of the inhalational anesthetic sevoflurane and the intravenous anesthetic propofol.

Interventions

None listed

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 19 years and older * Patients undergoing liver transplantation who are scheduled to receive anesthesia with the inhaled anesthetic sevoflurane or the intravenous anesthetic propofol.

Exclusion criteria

* Individuals with hearing loss, cognitive impairment or obvious dementia, hepatic encephalopathy, or difficulty in communication. * Diagnosed with neurological disorders (e.g., brain hemorrhage, stroke, dementia, Parkinson's disease, cognitive impairment, etc.).

Design outcomes

Primary

MeasureTime frameDescription
incidence of postoperative deliriumfrom postoperative day 0 to postoperative day 7At least two times a day during the hospitalization period. Patients diagnosed with delirium using the CAM were evaluated for the duration, symptoms, and type of delirium (e.g., reduced awareness of the environment; poor cognitive skills; behavioral changes; and emotional disturbances). \*\* Confusion assessment methods(CAM) diagnostic algorism (positive or negative result, positive means delirium) CAM is considered positive if features 1 and 2 are present, with at least one of features 3 or 4. Below are the four criteria of features : 1. Acute onset and fluctuating course Determined by collateral history or repeated clinic assessment 2. Inattention Counting from 20-1 is a simple (if blunt) test for this 3. Disorganized thinking 4. Altered levels of consciousness

Secondary

MeasureTime frameDescription
comprehensive geriatric assessment(CGA)Participants will be followed for the duration of their hospital stay and until their visit within one month after discharge, with an expected average of 4 weeksCore component of CGA are as follows : The Korean version of the fatigue, resistance, ambulation, illnesses, and loss of weight (K-FRAIL) scale : 0(healthy)\ 8(frail) Mini Nutritional Assessment(MNA) : 0 (malnutrition)\ 14(normal) Geriatric Depression Scale(GDS) : 0(normal)\ 15(depression) Instrumental Activities of Daily Living(IADL)-Lawton-Brody Scale : 0\ 8(complete independence)
duration of deliriumParticipants will be followed for the duration of their hospital stay and until their visit within one month after discharge, with an expected average of 4 weeksDuration of Delirium: The duration of delirium is measured from the onset to the resolution of symptoms, recorded in hours or days (e.g., 1 day, 3 days, 5 days).
total score of QOR-40Participants will be followed for the duration of their hospital stay and until their visit within one month after discharge, with an expected average of 4 weeksThe Quality of Recovery-40 (QoR-40) 40\ 200(better recovery)
type of deliriumParticipants will be followed for the duration of their hospital stay and until their visit within one month after discharge, with an expected average of 4 weeksType of Delirium: Delirium is classified into three types: hyperactive, hypoactive, and mixed.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026